A carregar...

Targeted therapy in HER2-positive breast cancer

Treatment options for breast cancer vary based on tumor surface markers and clinical factors, including cytotoxic chemotherapy, hormonal therapy, biological therapy or a combination thereof. An important molecular determinant of therapy is the human epidermal growth factor receptor 2 (HER2) positivi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: LI, SHU GUANG, LI, LI
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3917005/
https://ncbi.nlm.nih.gov/pubmed/24648975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2013.95
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!